The effects of acute and prolonged CRAM supplementation on reaction time and subjective measures of focus and alertness in healthy college students
© Hoffman et al; licensee BioMed Central Ltd. 2010
Received: 12 November 2010
Accepted: 15 December 2010
Published: 15 December 2010
The purpose of this study was to examine the effect of acute and prolonged (4-weeks) ingestion of a supplement designed to improve reaction time and subjective measures of alertness, energy, fatigue, and focus compared to placebo.
Nineteen physically-active subjects (17 men and 2 women) were randomly assigned to a group that either consumed a supplement (21.1 ± 0.6 years; body mass: 80.6 ± 9.4 kg) or placebo (21.3 ± 0.8 years; body mass: 83.4 ± 18.5 kg). During the initial testing session (T1), subjects were provided 1.5 g of the supplement (CRAM; α-glycerophosphocholine, choline bitartrate, phosphatidylserine, vitamins B3, B6, and B12, folic acid, L-tyrosine, anhydrous caffeine, acetyl-L-carnitine, and naringin) or a placebo (PL), and rested quietly for 10-minutes before completing a questionnaire on subjective feelings of energy, fatigue, alertness and focus (PRE). Subjects then performed a 4-minute quickness and reaction test followed by a 10-min bout of exhaustive exercise. The questionnaire and reaction testing sequence was then repeated (POST). Subjects reported back to the lab (T2) following 4-weeks of supplementation and repeated the testing sequence.
Reaction time significantly declined (p = 0.050) between PRE and POST at T1 in subjects consuming PL, while subjects under CRAM supplementation were able to maintain (p = 0.114) their performance. Significant performance declines were seen in both groups from PRE to POST at T2. Elevations in fatigue were seen for CRAM at both T1 and T2 (p = 0.001 and p = 0.000, respectively), but only at T2 for PL (p = 0.029). Subjects in CRAM maintained focus between PRE and POST during both T1 and T2 trials (p = 0.152 and p = 0.082, respectively), whereas significant declines in focus were observed between PRE and POST in PL at both trials (p = 0.037 and p = 0.014, respectively). No difference in alertness was seen at T1 between PRE and POST for CRAM (p = 0.083), but a significant decline was recorded at T2 (p = 0.005). Alertness was significantly lower at POST at both T1 and T2 for PL (p = 0.040 and p = 0.33, respectively). No differences in any of these subjective measures were seen between the groups at any time point.
Results indicate that acute ingestion of CRAM can maintain reaction time, and subjective feelings of focus and alertness to both visual and auditory stimuli in healthy college students following exhaustive exercise. However, some habituation may occur following 4-weeks of supplementation.
Phosphatidylcholine is a phospholipid that is a major constituent of all cellular membranes and is necessary for normal cellular function. It has an important role in the membrane's structural integrity and plays a vital role in supporting membrane expansion as the cells grow . Phosphatidylcholine has a number of important physiological functions in the liver, gastrointestinal tract, kidneys, brain and in neuromuscular signal transmission. It is the latter role that may have a potential ergogenic effect during exercise. Choline is an essential nutrient that has an important function in synthesis of the neurotransmitter acetylcholine.
Neurons are unable to synthesize choline and rely on dietary intake to insure sufficient acetylcholine production . Acetylcholine is critical for many physiological functions and any deficiency could result in a multitude of physiological problems. One of the more interesting findings has been the benefit that choline supplementation has had on memory and cognition improvements [3–6]. The importance of enhancing neurotransmitter function has interesting implications for athletic performance. Exercise that reduces plasma choline concentrations (i.e. marathon running) has been suggested to benefit from choline supplementation [7, 8]. However, support for this hypothesis has been lacking [9, 10]. This may be related to the inability of prolonged exercise to deplete plasma choline concentrations to levels that result in performance decrements [9, 10]. However, if choline can improve neurotransmitter concentration then it stands to reason that it may have a potential ergogenic role in athletic events that involve power performance and the ability to react to external stimuli, even during events that plasma choline concentrations are normal. Choline, provided as phosphatidylcholine, is 12-fold more effective than inorganic choline salts in increasing serum concentrations and maintaining elevated concentrations for a longer duration (12 hours versus 30 minutes) [11, 12]. Thus, most supplement studies will provide choline as phosphatidylcholine or L-Alpha Glycerylphosphorylcholine (alpha-GPC), a water-soluble form lacking the hydrophobic tail groups. In addition to being an excellent source of choline, acute alpha-GPC supplementation has been shown to augment growth hormone response to resistance exercise .
Phosphatidylserine is also a phospholipid that is incorporated into the membrane of organs with high metabolic activity such as brain, heart, lung, liver and skeletal muscle [14, 15]. Several studies have demonstrated that phosphatidylserine may reduce inflammation ([16, 17] and act as an antioxidant [18, 19]. These properties have led to additional investigations on the ability of phosphatidylserine to enhance recovery from exercise. A 750 mg dosing of phosphatidylserine for 7 days prior to an acute bout of exhaustive exercise resulted in significant improvements in sprint performance  and an increase in time to exhaustion during intermittent cycling exercise . Starks and colleagues  reported a lowered stress response to moderate intensity cycling exercise (65% - 85% VO2max) following 10 days of supplemention with 600 mg of phosphatidylserine, reflected by a reduced cortisol response to exercise. However, Kingsley and colleagues  were unable to support an improved recovery in individuals performing an acute bout of eccentric exercise (downhill running).
Investigations examining the combination of these phospholipids on enhancing exercise performance are limited, especially in exercise involving power performance and reaction time. Thus, the purpose of this study was to examine the acute effect of a low-dose combination of these phospholipids on reaction time, anaerobic power and subjective measures of alertness, energy, fatigue, and focus in health college students.
Nineteen subjects (17 men and 2 women) volunteered for this study. Following an explanation of all procedures, risks, and benefits, each subject gave their informed consent to participate in this study. The Institutional Review Board of the College approved the research protocol. Subjects were not permitted to use any additional nutritional supplements throughout the experimental period. Screening for supplement use was accomplished via a health history questionnaire completed by the subjects during recruitment. All subjects were recreationally active for at least three months prior to the investigation.
Subjects were randomly assigned to a group that either consumed the supplement (21.1 ± 0.6 years; height: 180.2 ± 6.1 cm; body mass: 80.6 ± 9.4 kg; body fat %: 11.3 ± 6.9%) or a placebo (21.3 ± 0.8 years; height: 181.3 ± 10.2 cm; body mass: 83.4 ± 18.5 kg; body fat %: 14.9 ± 7.7%). The study was conducted in a double-blind format.
Subjects reported to the Human Performance Laboratory on two separate occasions (T1 and T2) for testing. Each testing session was separated by 4-weeks. Subjects were instructed to refrain from consuming any caffeine products on the day of each testing session and from performing any strenuous physical activity for the previous 12 hours. In addition, subjects were instructed not to eat or drink for 3 hours prior to each trial. Following a 10-min resting period subjects were provided with either the supplement (CRAM) or the placebo (PL). Subjects then rested quietly for 10-minutes prior to completing a 9-question survey ascertaining their subjective feelings for that moment relating to alertness, energy, fatigue, focus, and well-being. Following the survey subjects performed a 4-min reaction test (PRE). Upon completion of the reaction test subjects performed an additional 10-min of exhaustive exercise before repeating the survey and reaction test (POST). Prior to the onset of the initial reaction test all subjects performed a 5-minute warm-up on a cycle ergometer and a standardized movement-specific warm-up that included a short sprint, side shuffles and a backwards run. The exhaustive exercise period consisted of a 30-second Wingate Anaerobic Power test, maximal number of push-ups for one-minute and the maximal number of sit-ups within a one-minute period.
Reaction time was assessed using the Makoto testing device (Makoto USA, Centennial CO). The Makoto device is triangular in shape that is eight feet from base to apex. It consists of three steel towers that are six feet high. Each tower contains ten targets. For each test the subject stood in the middle of the triangle and faced one of the towers with the other two in his/her peripheral vision. The reaction test began with a loud auditory stimulus. During the next four minutes subjects were required to react to both a visual (targets light up) and auditory (loud gong) stimulus. As the gong sounded and the light on the target lit up the subject was required to lunge and make contact with the target with their hands. Subjects had to make contact to the target prior to the light and sound stopping. If the subject made contact with the target within the required time it was registered as a 'hit'. Subjects were required to make as many contacts as possible within the 4-min period.
All subjects completed familiarization sessions on the Makoto device prior to entering the study. To enroll in the study subjects were required to achieve 65% success rate at level 8 on the Makoto device for two consecutive sessions. Subjects performed on average 4.1 ± 0.8 familiarization sessions. To maintain technique and skill on the Makoto device during the 4-week supplementation period subjects continued to perform a single 4-minute trial once per week.
Anaerobic Power Measure
To quantify anaerobic power performance all subjects performed a modified Wingate Anaerobic Power test (Lode Excalibur, Groningen, The Netherlands). After a warm-up period of 5 min of pedaling at 60 rpm interspersed with an all-out sprint lasting 5 s, the subjects pedaled for 30 sec at maximal speed against a constant force (1.0 Nm·kg-1). Peak power, mean power, time to peak power, total work and a fatigue index were determined. Peak power was defined as the highest mechanical power output elicited during the test. Mean power was defined as the average mechanical power during the 30 sec test. Fatigue index was determined by dividing the highest power output by the lowest power output.
Subjects were instructed to assess their subjective feelings of energy, fatigue, alertness, and focus using a 15 cm visual analog scale (VAS). The VAS was assessed immediately before commencing each reaction test. Subjects were asked to assess via a mark on a 15-cm straight line, with words anchored at each end of the line, their feelings at that time. Questions were structured as "My level of focus is:" with low and high serving as the verbal anchor representing the extreme ratings. Similarly, "My level of energy is:" was anchored with the verbal cues "low" and "high", and while "My level of fatigue:" was anchored with the verbal cues "high" and "low". For fatigue, a higher score indicated greater fatigue. The validity and reliability of VAS in assessing fatigue and energy has been previously established 
On the initial visit subjects consumed one serving (3 capsules) of either the supplement or placebo. Each serving of CRAM consisted of α-glycerophosphocholine (150 mg), choline bitartrate (125 mg), phosphatidylserine (50 mg), niacin (vitamin B3; 30 mg), pyridoxine HCl (vitamin B6; 30 mg), methylcobalamin (vitamin B12; 0.06 mg), folic acid (4 mg), L-tyrosine (500 mg), anhydrous caffeine (60 mg), acetyl-L-carnitine (500 mg), and naringin (20 mg). The placebo was similar in appearance to the supplement, but contained only an inert substance (rice flour). Subjects ingested the capsules with 12 ounces of bottled water.
Statistical analysis of the data was accomplished using a 2 × 2 (time × treatment) mixed factorial analysis of variance. In the event of a significant F-ratio, Tukey post-hoc tests were used for pairwise comparisons. Chi-square analysis was used to compare responses between CRAM and PL groups on the yes/no survey questions. A criterion alpha level of p ≤ 0.05 was used to determine statistical significance. All data are reported as mean ± SD.
Acute and Prolonged Effects of CRAM supplementation on Power and Muscle Endurance Performance
PP (W·kg -1 )
MP (W·kg -1 )
Fatigue (W·s -1 )
971 ± 119
621 ± 40
11.6 ± 1.5
7.4 ± 0.9
18627 ± 1189
20.5 ± 4.2
44.6 ± 12.6
33.1 ± 9.3
1009 ± 139
611 ± 40
12.7 ± 0.9
7.8 ± 0.7
18340 ± 1184
25.0 ± 7.2
43.4 ± 14.4
34.3 ± 9.2
1018 ± 307
633 ± 140
12.6 ± 2.0
7.5 ± 1.5
18174 ± 2875
25.6 ± 10.9
42.5 ± 10.8
35.3 ± 12.7
1058 ± 317
603 ± 114
12.9 ± 2.6
7.7 ± 1.5
18083 ± 3419
23.8 ± 7.1
44.2 ± 10.9
37.7 ± 10.6
Results of this study indicated that acute ingestion of CRAM can maintain reaction time to both visual and auditory stimuli following a high-intensity bout of exhaustive exercise, while subjects consuming a placebo experienced significant reductions in performance. In addition, acute ingestion of CRAM resulted in maintained focus and alertness following exhaustive exercise, while subjects consuming a placebo experienced significant declines in focus and alertness. Following 4 weeks of supplementation both groups exhibited significant declines in reaction performance. However, subjects consuming CRAM were still able to maintain their focus following exhaustive exercise, while subjects consuming a placebo did not.
Previous investigators have suggested that choline supplementation may provide an ergogenic benefit during prolonged or exhaustive exercise [1, 7, 8]. This has been based primarily on the assumption that exhaustive exercise may lower acetylcholine concentrations resulting in fatigue and lowered exercise performance. The basis of choline supplementation is that free choline can increase the rate of acetylcholine synthesis [24, 25]. If acetylcholine levels become reduced during exhaustive exercise, supplementing with choline may maintain neurotransmitter concentrations and reduce fatigue and maintain performance. However, Spector and colleagues  reported that exercising until exhaustion at 70% of VO2max did not deplete choline. This is consistent with other studies reporting that choline concentrations may not be depleted during prolonged exercise [9, 10], but contrasts with other studies showing reduced plasma choline concentrations during prolonged exercise [7, 27, 28]. Differences between these studies are difficult to explain considering that endurance exercise was the mode examined in these investigations, and subject populations were both recreationally and competitively-trained individuals. More consistent findings have been reported in choline's ability to enhance cognition and memory [5, 7, 29]. However, reports of enhanced memory or cognition following choline supplementation following a physical stress are limited. Only one study examined choline's potential to enhance cognitive performance following a physical stress, and results did not prove to be efficacious . To date, it appears that the benefit of choline supplementation is inconclusive.
In contrast to the majority of research on choline ingestion, the present study incorporated relatively short-duration, high intensity anaerobic exercise protocol to elicit fatigue. Furthermore, the supplement ingested contained smaller concentrations of choline than has been previously shown to be efficacious. Despite these differences, the combination of other dietary ingredients appeared to have provided a positive effect on performance and subjective feelings of fatigue and alertness. To maximize the effectiveness of a supplement many sport nutrition companies combine several ingredients to provide a synergistic effect. The CRAM supplement combined choline (as α-glycerophosphocholine and choline bitartrate) with phosphatidylserine, carnitine, an energy matrix (caffeine and tyrosine) and vitamins. Phosphatidylserine has been previously shown to enhance recovery following high- and moderate-intensity exercise [1, 15, 20–22]. In addition, phosphatidylserine has been shown to enhance subjective feelings of energy, elation and confidence in healthy students subjected to stressful mental tasks  and in combination with carbohydrates to improve performance in golfers during induced stress . Carnitine supplementation has been shown to enhance recovery following high intensity exercise [32, 33], as reflected by reduced markers of muscle damage and a greater anabolic response (elevation in IGF binding protein) to exercise recovery. Although the vitamins included in CRAM are not known to be ergogenic when no deficiencies are present, the energy matrix found in this supplement has been shown to be effective in delaying time to fatigue and increasing volume of training .
The ability to maintain reaction performance following fatigue may have been due to the combined effect of choline, phosphatidylserine and the energy matrix. Although this is the first investigation to examine this combination of ingredients following exhaustive anaerobic exercise, previous studies have shown that this combination of ingredients to be effective in augmenting exercise  and cognitive  performance in rodents. Although the mechanism of action has not been fully elucidated, it has been suggested that this combination of ingredients may contribute to an enhanced neuroprotective effect via a stronger defense of membrane integrity . Glycerophosphocholine and phosphatidylserine have been shown to form membrane phospholipids , and acetyl-L-carnitine may provide neuroprotective effects by buffering oxidative stress and maintaining energy supply to neurons . The concentrations of ingredients used in CRAM appear to have been sufficient to maintain performance during T1; however, did not appear to provide the same effect at T2. This may have been due to habituation in that the daily concentration of ingredients ingested may not have provided the same physiological effect following 4 weeks of supplementation. Another potential explanation is that the weekly familiarization sessions that continued throughout the experimental period may have provided a training effect thereby making it more difficult for CRAM to affect performance at the same concentrations. However, the use of weekly familiarization sessions was critical to our study design to limit potential detraining effects. Thus, future research should address the role of chronic CRAM supplementation on acute exercise performance.
Despite the habituation effect observed for reaction time and subjective feelings of alertness, subjects' subjective feelings of focus in CRAM was maintained following the bout of high intensity exercise while subjects in PL experienced a significant decline. In conclusion, the results of this study indicate that acute ingestion of CRAM can prevent the exercise-induced decline of reaction time, and subjective feelings of focus and alertness in healthy college students following exhaustive exercise. However, some habituation may occur following 4-weeks of supplementation. Future investigations appear warranted to provide further insight on the efficacy of long-term supplementation of CRAM.
The authors would like to thank Chemi Nutra, Inc. (White Bear Lake, MN) for providing financial support of this study and MRM (Oceanside, CA) for providing the study material.
- Jäger R, Purpura M, Kingsley M: Phospholipids and sports performance. J Int Soc Sports Nutr. 2007, 4: 5-PubMed CentralView ArticlePubMedGoogle Scholar
- Amenta F, Tayebati SK: Pathwasy of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. Curr Med Chem. 2008, 15: 488-498. 10.2174/092986708783503203.View ArticlePubMedGoogle Scholar
- Buchman AL, Sohel M, Brown M, Jenden DJ, Ahn C, Roch M, Brawley TL: Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: a pilot study. J Parenter Enteral Nutr. 2001, 25: 30-35. 10.1177/014860710102500130.View ArticleGoogle Scholar
- Canal N, Franceschi M, Alberoni M, Castiglioni C, De Moliner P, Longoni A: Effect of L-alpha-glyceryl-phoshorylcholine on amnesia caused by scopolamine. Int J Clin Pharmacol Ther Toxicol. 1991, 29: 103-107.PubMedGoogle Scholar
- DiPerri R, Coppola G, Ambrosio LA, Grasso A, Puca FM, Rizzo M: A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cystosine diphosphocholine in patients with vascular dementia. J Int Med Res. 1991, 19: 330-341.Google Scholar
- Gossell-Williams M, Simon O, Young L, West M: Choline supplementation facilitates short-term memory consolidation into intermediate long-term memory of young Sprague-Dawley rats. West Indian Med J. 2006, 55: 4-8.PubMedGoogle Scholar
- Conlay LA, Wurtman RJ, Blusztajn JK, Coviella ILG, Maher TJ, Evoniuk GE: Decreased plasma choline concentrations in marathon runners. N Engl J Med. 1986, 315: 892-PubMedGoogle Scholar
- Penry JT, Manore MM: Choline: an important micronutrient for maximal endurance-exercise performance?. Int J Sport Nutr Exerc Metab. 2008, 18: 191-203.PubMedGoogle Scholar
- Deuster PA, Singh A, Coll R, Hyde DE, Becker WJ: Choline ingestion does not modify physical or cognitive performance. Mil Med. 2002, 167: 1020-1025.PubMedGoogle Scholar
- Warber JP, Patton JF, Tharion WJ, Zeisel SH, Mello RP, Kemnitz CP, Lieberman HR: The effects of choline supplementation on physical performance. Int J Sport Nutr Exerc Metab. 2000, 10: 170-181.PubMedGoogle Scholar
- Hirsch MJ, Growdon JH, Wurtman RJ: Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indices. Metabolism. 1978, 27: 953-960. 10.1016/0026-0495(78)90139-7.View ArticlePubMedGoogle Scholar
- Wurtman RJ, Hirsch MJ, Growdon JH: Lecithin consumption raises serum-free-choline levels. Lancet. 1977, 2: 68-69. 10.1016/S0140-6736(77)90067-8.View ArticlePubMedGoogle Scholar
- Ziegenfuss T, Landis J, Hofheins J: Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. J Int Soc Sports Nutr. 2008, 5 (Suppl 1): P15-10.1186/1550-2783-5-S1-P15.PubMed CentralView ArticleGoogle Scholar
- Blokland A, Honig W, Browns F, Jolles J: Cognition-enhancing properties of subchronic phosphatidylserine (ps) treatment in middle-aged rats: comparision of bovine cortex ps with eggs ps and soybean ps. Nutrition. 1999, 15: 778-783. 10.1016/S0899-9007(99)00157-4.View ArticlePubMedGoogle Scholar
- Starks MA, Starks SL, Kingsley M, Purpura M, Jäger R: The effects of phosphotidylserine on endocrine response to moderate intensity exercise. J Inter Soc Sports Nutr. 2008, 5: 11-10.1186/1550-2783-5-11.View ArticleGoogle Scholar
- Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes tgf-β1 secretion and the resolution of inflammation. J Clin Invest. 2002, 109: 41-50.PubMed CentralView ArticlePubMedGoogle Scholar
- Monteleone P, Beinat L, Tanzillo C, Maj M, Kemall D: Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. Neuroendocrinology. 1990, 52: 243-248. 10.1159/000125593.View ArticlePubMedGoogle Scholar
- Dacaranhe CD, Terao J: A unique antioxidant activity of phosphatidylserine on iron-induced lipid peroxidation of phospholipid bilayers. Lipids. 2001, 36: 1105-1110. 10.1007/s11745-001-0820-7.View ArticlePubMedGoogle Scholar
- Lactorraca S, Piersanti P, Tesco G, Piacentini S, Amaducci L, Sorbi S: Effect of phosphatidylserine on free radical susceptibility in human diploid fibroblasts. J Neural Transm Park Dis Dement Sect. 1993, 6: 73-77. 10.1007/BF02252625.View ArticleGoogle Scholar
- Kingsley M, Wadsworth D, Kilduff LP, McEneny J, Benton D: Effects of phosphatidylserine on oxidative stress following intermittent running. Med Sci Sports Exerc. 2005, 37: 1300-1306. 10.1249/01.mss.0000175306.05465.7e.View ArticlePubMedGoogle Scholar
- Kingsley M, Miller M, Kilduff LP, McEneny J, Benton D: Effects of phosphatidylserine on exercise capacity during cycling in active males. Med Sci Sports Exerc. 2006, 38: 64-71. 10.1249/01.mss.0000183195.10867.d0.View ArticlePubMedGoogle Scholar
- Kingsley M, Kilduff LP, McEneny J, Dietzig R, Benton D: Phosphatidylserine supplementation and recovery following downhill running. Med Sci Sports Exerc. 2006, 38: 1617-1625. 10.1249/01.mss.0000183195.10867.d0.View ArticlePubMedGoogle Scholar
- Lee KA, Hicks G, Nino-Murcia G: Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991, 36: 291-298. 10.1016/0165-1781(91)90027-M.View ArticlePubMedGoogle Scholar
- Haubrich DR, Wang PFL, Clody DE, Wedeking PW: Increase in rat brain acetylcholine induced by choline or deanol. Life Sci. 1975, 17: 975-980. 10.1016/0024-3205(75)90451-8.View ArticlePubMedGoogle Scholar
- Trammer BA, Schmidt DE, Wecker L: Exogenous choline enhances the synthesis of acetylcholine only under conditions of increased cholinergic neuronal activity. J Neurochem. 1982, 39: 1704-1709. 10.1111/j.1471-4159.1982.tb08006.x.View ArticleGoogle Scholar
- Spector SA, Jackman MR, Sabounjian LA, Sakkas C, Landers DM, Willis WT: Effect of choline supplementation on fatigue in trained cyclists. Med Sci Sports Exerc. 1995, 27: 668-673.View ArticlePubMedGoogle Scholar
- Conlay LA, Sabounjian LA, Wurtman RJ: Exercise and neuromodulators: choline and acetylcholine in marathon runners. Int J Sports Med. 1992, 13: S141-S142. 10.1055/s-2007-1024619.View ArticlePubMedGoogle Scholar
- Van Allworden HN, Horn S, Kahl J, Feldheim W: The influence of lecithin on plasma choline concentrations in triathletes and adolescent runners during exercise. Eur J Appl Physiol. 1993, 67: 87-91. 10.1007/BF00377711.View ArticleGoogle Scholar
- Moreno MDJM: Cognitive improvement in mild to moderate alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. 2003, 25: 178-193. 10.1016/S0149-2918(03)90023-3.View ArticleGoogle Scholar
- Benton D, Donohoe RT, Silance B, Nabb S: The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor. Nutr Neurosci. 2001, 4: 169-178.PubMedGoogle Scholar
- Jäger R, Purpura M, Geiss KR, Weiß M, Baumeister J, Amatulli F, Schröder L, Herwegen H: The effect of phosphatidylserine on golf performance. J Int Soc Sports Nutr. 2007, 4: 23-PubMed CentralView ArticlePubMedGoogle Scholar
- Kraemer WJ, Volek JS, French DN, Rubin MR, Sharman MJ, Gómez AL, Ratamess NA, Newton RU, Jemiolo B, Craig BW, Häkkinen K: The effects of L-carnitine L-tartrate supplementation on hormonal responses to resistance exercise and recovery. J Strength Cond Res. 2003, 17: 455-462.PubMedGoogle Scholar
- Volek JS, Kraemer WJ, Rubin MR, Gómez AL, Ratamess NA, Gaynor P: L-Carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress. Am J Physiol Endocrinol Metab. 2002, 282: E474-482.View ArticlePubMedGoogle Scholar
- Hoffman JR: Caffeine and Energy Drinks. Strength and Cond J. 2010, 12: 15-20. 10.1519/SSC.0b013e3181bdafa0.View ArticleGoogle Scholar
- Sachan DS, Hongu N: Increases in VO2max and metabolic markers of fat oxidation by caffeine, carnitine, and choline supplementation in rats. J Nutr Biochem. 2000, 11: 521-526. 10.1016/S0955-2863(00)00119-4.View ArticlePubMedGoogle Scholar
- Suchy J, Chan A, Shea TB: Dietary supplementation with a combination of α-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutr Res. 2009, 29: 70-74. 10.1016/j.nutres.2008.11.004.View ArticlePubMedGoogle Scholar
- Kidd PM: Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev. 2005, 10: 268-293.PubMedGoogle Scholar
- Dhitavat S, Ortiz D, Shea TB, Rivera ER: Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem Res. 2002, 27: 501-505. 10.1023/A:1019800703683.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.